BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Former bluebird CMO David Davidson Lands Exec Role at Tessera Therapeutics

  Davidson is one of three new executives to join Cambridge, Mass.-based Tessera.

  April 7, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  TrialJectory IDs Barriers to Oncology Clinical Trial Enrollment, Improving Trial Design

  Insights into barriers that cause cancer patients not to enroll in specific trials are helping pharmaceutical companies adjust their trial designs and assumptions.

  April 7, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Ionis’ Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More

  Ionis Pharmaceuticals unleashed a string of news releases about activities at the company, including a partnership with Progenity and the launch of a Phase III trial for amyotrophic lateral sclerosis.

  April 7, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  NIH to Back First Phase II Trials for COVID-19 Therapy Targeting Viral Proteases

  The $3.1 million NCATS grant will help the company test SPI-1005 in two trials, both OK’d by the U.S. Food and Drug Administration (FDA) last August.

  April 7, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  Drug Development

  COVID-19 Long Haulers: Real-Time Research Clarifying the Condition

  The landscape may begin to become clearer as real-time research continues to emerge about the long-term effects of COVID-19 infection.

  April 7, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Career Advice

  Why Should Biotech Companies Invest in Leadership Development Program?

  Reasons for investing in leadership development program in the biotech industry are divided into need and opportunity. Read the proper opportunity divisions here.

  April 7, 2021

   · 

  4 min read

   · 

  Karen Walpole
• 

  Business

  Artios, Novartis Aim to Develop and Discover DDR Targets for Cancer in New Partnership

  Artios Pharma Limited has entered into a global research collaboration with Novartis for the purpose of discovering and validating next-generation DDR targets and enhancing Novartis’ radioligand therapies.

  April 7, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Policy

  FDA Extends Supplemental NDA Review Period for Lilly and Incyte’s Atopic Dermatitis Drug

  The action data was extended by the agency to provide more time to review new data analyses submitted by Lilly, per information requests made by the FDA.

  April 7, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Global Roundup: Sanofi Launches Nonprofit Unit to Supply Essential Medicines

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

  April 7, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Deals

  Vaccitech Confidentially Files for IPO in the US

  At this time Vaccitech hasn’t priced its offering, although the report suggests they might sometime this month.

  April 7, 2021

   · 

  5 min read

   · 

  Mark Terry